Tekla Capital Management LLC Bei Gene, Ltd. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Tekla Capital Management LLC holds 20,952 shares of BGNE stock, worth $2.99 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

20,952

Previous 20,952 -0.0%

Holding current value

$2.99 Million

Previous $4.52 Million 17.28%

% of portfolio

0.15%

Previous 0.17%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$131.8 - $202.24 $3.96 Million - $6.08 Million	-30,066 Reduced 58.93%	20,952 $2.83 Million
Q1 2022 May 13, 2022	SELL	$146.52 - $269.56 $1.87 Million - $3.44 Million	-12,754 Reduced 20.0%	51,018 $9.62 Million
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $4.44 Million - $7.17 Million	17,789 Added 38.69%	63,772 $23.1 Million
Q2 2021 Aug 13, 2021	BUY	$292.75 - $367.01 $1.64 Million - $2.05 Million	5,594 Added 13.85%	45,983 $15.8 Million
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $3.16 Million - $4.63 Million	12,109 Added 42.82%	40,389 $14.1 Million

Q3 2020 Nov 13, 2020	SELL	$189.18 - $286.44 $8.84 Million - $13.4 Million	-46,704 Reduced 62.29%	28,280 $8.1 Million
Q1 2020 May 14, 2020	SELL	$121.84 - $173.19 $743,833 - $1.06 Million	-6,105 Reduced 7.53%	74,984 $9.23 Million
Q4 2019 Feb 13, 2020	SELL	$115.78 - $208.34 $1.53 Million - $2.75 Million	-13,200 Reduced 14.0%	81,089 $13.4 Million
Q3 2019 Nov 13, 2019	SELL	$120.61 - $148.29 $72,366 - $88,974	-600 Reduced 0.63%	94,289 $11.5 Million
Q1 2019 May 14, 2019	BUY	$122.82 - $151.83 $1.12 Million - $1.39 Million	9,134 Added 10.65%	94,889 $12.5 Million
Q3 2018 Nov 13, 2018	BUY	$152.62 - $189.66 $4.73 Million - $5.87 Million	30,970 Added 56.53%	85,755 $14.8 Million
Q2 2018 Aug 13, 2018	BUY	$152.5 - $216.77 $806,572 - $1.15 Million	5,289 Added 10.69%	54,785 $8.42 Million
Q1 2018 May 14, 2018	BUY	$97.41 - $177.22 $2.27 Million - $4.13 Million	23,326 Added 89.13%	49,496 $8.32 Million
Q4 2017 Feb 14, 2018	BUY	$79.6 - $114.73 $2.08 Million - $3 Million	26,170	26,170 $2.56 Million

Others Institutions Holding BGNE

# of Institutions

216

Shares Held

45.1M

Call Options Held

76.5K

Put Options Held

72.3K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $14.8B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Bei Gene, Ltd. Transaction History